Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 9Gastrointestinal 8Thoracic 4Lymphoid 3Sarcoma 2Other hematologic neoplasm 2Gynecologic 2Tumor-Agnostic 1Plasma cell 1Head & Neck 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Enoxaparin × Thoracic × Clear all
NCT01058759 2018-08-22

Taxotere-Enoxaparin-(ENOXA)-Study

Hannover Medical School

Phase 3 Terminated
14 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00717938 2017-08-25

RASTEN

Lund University Hospital

Phase 3 Completed
390 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00771563 2013-06-28

SYRINGES

University Hospital, Antwerp

Phase 3 Completed
104 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00916669 2013-05-08

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Massachusetts General Hospital

Phase 2 Withdrawn
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡